To guide health care professionals in Belgium in selecting the appropriate antiepileptic drugs (AEDs) for their epilepsy patients, a group of Belgian epilepsy experts developed recommendations for AED treatment in adults and children. As new drugs have become available, others have been withdrawn, new indications have been approved and recommendations for pregnant women have changed, a new update was pertinent. The current update also covers other important aspects related to the management of epilepsy, including the importance of early referral in drug-resistant epilepsy, pharmacokinetic properties and tolerability of AEDs, comorbidities, specific considerations in elderly and pregnant patients, generic substitution and the rapidly evolving field of precision medicine.
Prof Boon (UGent) and Prof Lagae (KULeuven) are sharing here the result of their discussion
Ghent University Hospital
Reference Center for Refractory Epilepsy, Department of Neurology
Neurology
Geaccrediteerd voor artsen (N° 21023772 - 1.5 punten)
Cardiology
Geaccrediteerd voor artsen (N° 21013728 - 1 punt)
Healthcare
Geaccrediteerd voor artsen (N° 21007826 - 1 punt)
Geaccrediteerd voor artsen (21023772 - 1,5CP)
Geaccrediteerd voor artsen (21013728 - 1CP)
Geaccrediteerd voor artsen - 21007826 - 1CP Ethiek en Economie
